Page last updated: 2024-11-04

vorinostat and Alveolitis, Fibrosing

vorinostat has been researched along with Alveolitis, Fibrosing in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Research Excerpts

ExcerptRelevanceReference
"Idiopathic pulmonary fibrosis (IPF) is a deadly disease characterized by chronic inflammation and excessive collagen accumulation in the lung."1.39Histone deacetylase inhibition downregulates collagen 3A1 in fibrotic lung fibroblasts. ( Hock, T; Liu, H; Sanders, YY; Thannickal, VJ; Zhang, X, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, X1
Liu, H1
Hock, T1
Thannickal, VJ1
Sanders, YY1

Other Studies

1 other study available for vorinostat and Alveolitis, Fibrosing

ArticleYear
Histone deacetylase inhibition downregulates collagen 3A1 in fibrotic lung fibroblasts.
    International journal of molecular sciences, 2013, Sep-27, Volume: 14, Issue:10

    Topics: Animals; Cells, Cultured; Chromatin; Collagen Type III; Down-Regulation; Fibroblasts; Histone Deacet

2013